(NASDAQ: IFRX) InflaxRx N.V. shares are up more than 11% in pre-market trading on more than 3200 trades and increasing volume. Shares are $1.58 and volume is increasing on FDA news.

InflaRx Receives FDA Fast Track Designation for Treatment of Ulcerative Pyoderma Gangrenosum

https://www.globenewswire.com/news-release/2022/07/06/2474834/0/en/InflaRx-Receives-FDA-Fast-Track-Designation-for-Treatment-of-Ulcerative-Pyoderma-Gangrenosum.html

RelatedNews

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist